BioSpace News Archive

Pharm Country

MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula™ At The Atlantic Coast Veterinary Conference, October 8-11, 2018

MYOS RENS Technology Inc. announced today that MYOS will exhibit at the Atlantic Coast Veterinary Conference in Atlantic City, NJ, from October 8-11, 2018.

September 26, 2018
·
4 min read
BioCapital

Centric Home Health & Hospice Advances Care Coordination with Backline, DrFirst’s Secure Communication Platform

Backline facilitates rapid, real-time communication for mobile care team members

September 26, 2018
·
4 min read
Biotech Bay

RTI Surgical® Features Next-Generation Spine Implant Technologies at NASS 2018

Presentations reinforce RTI’s commitment to expanding its body of clinical data to optimize outcomes for spine patients

September 26, 2018
·
5 min read
Drug Development

Concert Pharmaceuticals Amends Protocol of Phase 2a Trial to Evaluate 12 mg Twice-Daily Dose Cohort of CTP-543 for the Treatment of Alopecia Areata

Company On Track to Report Topline Data from the 4 mg and 8 mg Twice-Daily Cohorts in Fourth Quarter of 2018

September 26, 2018
·
5 min read
Job Trends

Walton Family Foundation: Research Universities Catalyst to Economic Growth, on and off Campus in Heartland and Beyond

New research, “How Do Research Universities Contribute to Regional Economies?” outlines the critical role research universities play in growing local and regional economies across America’s Heartland and beyond.

September 26, 2018
·
2 min read
Biotech Beach

Avelas Biosciences to Present at 2018 Cantor Global Healthcare Conference

Avelas is a clinical stage oncology-focused platform technology company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic intervention.

September 26, 2018
·
1 min read
Pharm Country

Ocugen to Present at Two Upcoming Investor Conferences

Ocugen is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases

September 26, 2018
·
1 min read
FDA

Allergan Announces FDA Acceptance of Supplemental New Drug Application For VRAYLAR® (cariprazine)

- Application Seeks to Expand VRAYLAR Indication to Include the Treatment of Bipolar Depression

September 26, 2018
·
13 min read
Biotech Beach

Viking Therapeutics to Participate in Upcoming 2018 Investor Conferences

Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders

September 26, 2018
·
2 min read
Drug Development

Ra Pharma Announces Positive Results from Phase 1b Pharmacokinetic Study of Zilucoplan (RA101495 SC) in Patients with Renal Impairment

Study enables clinical development in complement-mediated renal disorders

September 26, 2018
·
5 min read